Form 4: Vita Coco CFO Sells Shares Under 10b5-1 Plan
Insider Trading Disclosure
Vita Coco Company's Chief Financial Officer, Corey Baker, sold 2,000 shares of common stock in early September 2025 through a pre-arranged trading plan.
Summary
- Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported sales of common stock.
- On September 5, 2025, 1,000 shares were sold at a price of $38.00 per share.
- On September 8, 2025, an additional 1,000 shares were sold at a price of $38.51 per share.
- These transactions were executed pursuant to a Rule 10b5-1 trading plan.
- Following these sales, Baker directly beneficially owns 41,754 shares of common stock.
- Baker also holds various non-qualified stock options with exercise prices ranging from $16.91 to $33.36, with vesting schedules extending through 2027 and beyond.
Sentiment
Score: 5
Explanation: Neutral. The filing is a routine disclosure of insider stock sales executed under a pre-arranged 10b5-1 plan, which is a common practice and generally not indicative of strong positive or negative sentiment regarding the company's immediate prospects.
Positives
- The sales were conducted under a Rule 10b5-1 trading plan, indicating pre-planned transactions and reducing concerns about opportunistic insider selling.
Negatives
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it reduces the insider's direct equity stake.
Future Outlook
The filing does not contain any forward-looking statements or guidance.
Industry Context
The filing is a routine insider trading disclosure and does not provide information relevant to broader industry trends or competitors.
Stakeholder Impact
- Shareholders: May view the sale as a slight reduction in insider alignment, though mitigated by the pre-arranged 10b5-1 plan, which suggests the sales are for personal financial planning rather than a reaction to new company-specific information.
Key Dates
| Date | Description |
|---|---|
| 2024-03-10 | Start of vesting for 14,205 non-qualified stock options with an exercise price of $16.91, vesting in four equal annual installments. |
| 2025-03-04 | Start of vesting for 8,746 non-qualified stock options with an exercise price of $26.18, vesting in four equal annual installments. |
| 2025-03-10 | Vesting of 30% of two tranches of non-qualified stock options (13,481 and 11,547 shares) which were 40% vested previously. |
| 2025-09-05 | Sale of 1,000 shares of common stock by Corey Baker at $38.00 per share. |
| 2025-09-08 | Sale of 1,000 shares of common stock by Corey Baker at $38.51 per share. |
| 2025-09-09 | Date of filing of the Form 4. |
| 2026-03-10 | Vesting of 20% of two tranches of non-qualified stock options (13,481 and 11,547 shares). |
| 2027-03-10 | Vesting of 10% of two tranches of non-qualified stock options (13,481 and 11,547 shares). |
| 2033-03-10 | Expiration date for 14,205 non-qualified stock options with an exercise price of $16.91. |
| 2033-05-10 | Expiration date for 13,481 non-qualified stock options with an exercise price of $24.35. |
| 2033-08-07 | Expiration date for 11,547 non-qualified stock options with an exercise price of $27.59. |
| 2034-03-04 | Expiration date for 8,746 non-qualified stock options with an exercise price of $26.18. |
| 2035-03-04 | Expiration date for 13,218 non-qualified stock options with an exercise price of $33.36. |
Recommendation
holdThe filing is a standard Form 4 disclosing routine insider stock sales by the CFO under a Rule 10b5-1 trading plan. Such pre-scheduled sales are common for executives for personal financial planning and typically do not signal a change in the company's fundamental outlook. There is no new information in this filing that would warrant a change in investment thesis, thus a 'hold' recommendation is appropriate.
Keywords
Vita Coco Company, COCO, Corey Baker, CFO, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Equity Sales, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.